BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Humanetics Corp.
/
Colin G. Chinn, M.D., MHS, FACP
CG
Colin G. Chinn, M.D., MHS, FACP
Chief Medical Officer
Humanetics Corp.
Therapeutic Areas
Oncology
Pulmonology
Biodefense
Humanetics Corp. Pipeline
Drug
Indication
Phase
BIO 300
Non-Small Cell Lung Cancer (with radiotherapy)
Phase 2
Leadership Team at Humanetics Corp.
RJ
Ronald J. Zenk, MBA
Leadership (likely CEO/President)
TE
Timothy E. Morris
Chief Operating Officer
BR
Barbara R. Holcomb, RN, BSN, MSN
Board Member
ML
Matthew L. Nathan, M.D.
Leadership
View full Humanetics Corp. profile